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Abstract
Genetic studies often use genomic DNA from whole blood cells, of which the majority are the polymorphonuclear myeloid
cells. Those cells undergo dramatic change of nuclear morphology following cellular differentiation. It remains elusive if the
nuclear morphological change accompanies sequence alternations from the intact genome. If such event exists, it will cause
a serious problem in using such type of genomic DNA for genetic study as the sequences will not represent the intact
genome in the host individuals. Using exome sequencing, we compared the coding regions between neutrophil, which is
the major type of polymorphonuclear cells, and CD4+ T cell, which has an intact genome, from the same individual. The
results show that exon sequences between the two cell types are essentially the same. The minor differences represented
by the missed exons and base changes between the two cell types were validated to be mainly caused by experimental
errors. Our study concludes that genomic DNA from whole blood cells can be safely used for genetic studies.
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Introduction
Genomic DNA from peripheral blood cells is routinely used for
genetic studies. For example, it is a common practice to use blood
DNA to distinguish germline variation and somatic mutation in
solid tumors [1–7]. Blood cells consist of multiple cell types of
myeloid and lymphoid lineages [8]. Myeloid cells are differentiated
rapidly from myeloid progenitors to myeloblasts and to mature
terminal cells of neutrophils, eosinophils, basophils and monocytes,
towards the end stage of cellular destruction by apoptosis, necrosis
or netrosis [9–10]. During differentiation, the nuclei of myeloid
cells transform from mononuclear to segmented and banded
polymorphonuclear shape of 2–5 lobes. Little is known if the
nuclear morphological transformation during myeloid differenti-
ation accompanies any genome sequence change. If such change
does exist, the sequences derived from blood cells containing
myeloid cells will reflect the genomes of mixed mononuclear and
polymorphonuclear cells. Interpretation of such heterogeneous
sequences will be problematic. While studies on selected genes
were performed [11], no systematic attempts have been reported
to determine, at genome level, the nature of genetic sequences in
polymorphonuclear myeloid cells. In this study, we used the
exome sequencing method [12] to analyze the entire coding
regions of neutrophils, the most abundant myeloid cells constitut-
ing 40–60% of nucleated cell counts in peripheral blood [9], and
compared the data with the mononuclear CD4+ T cells
represeenting the intact genome of the same individual. Our
study shows that the coding regions in the polymorphonuclear
neutrophils are essentially the same as the intact genome.
Results and Discussion
Using exome sequencing method, we analyzed the coding
regions between the genomes of polymorphonuclear neutrophils
and mononuclear CD4+ T cells from the same healthy individual.
our study detected 197,988 (98.5%) and 197,565 (98.3%) of the
targeted 201,046 human genome exons in neutrophils and in
CD4+ T cells respectively, of which 196,749 exons are the same
between the two cell types (Table 1). And there are 3,058 and
3,481 (1.5% and 1.7%) exons missed in neutrophils and CD4+ T
cells respectively, of which 2,242 are missed in both cell types and
the rest are missed in a single cell type (Table 1). Furthermore,
there are 150,719 SNVs detected in neutrophils and 150,203
SNVs in CD4+ T cells, of which 141,034 are common between
the two cell types, and 9,685 (6.4%) and 9,169 (6.1%) are only
present in neutrophils and CD4+ T cells, respectively (Table 2).
We used PCR to test if the missed exons reflect the true exon
differences or were caused by experimental artifacts. Based on
statistical analysis, we randomly picked 100 missed exons for the
validtion, which provide 88% of probability to test a missed exon.
Three types of results were generated: 1) 89 reactions detected the
targeted exons with the same size in both T cells and neutrophils,
implying that those missed exons are present in both T cells and
neutrophils (Figure 1); 2) 10 reactions failed to detect the missed
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exons in both T cells and neutrophils, implying that those exons
may not be present or may not be included in the exome kit-
targeted exons in this donor’s genome; and 3) 1 reaction (#73 in
Figure 1) detected the missed exons with different size in T cells
and neutrophils. This exon is for AIRE, a gene involved in
regulating auto-antigen expression and auto-reactive T-cell
negative selection. The results indicate that most of the exons
missed from exome data were caused by experimental failure,
likely missed during exome DNA capturing process, an event often
present in exome sequencing study [13]. We then used Sanger
sequencing to validate if the observed single-base differences
between T cells and neutrophils reflect the true variants bewtween
the two cell types, or if the differences were generated by
sequencing errors or miscalling. Based on statistical analysis, we
selected 40 candidates for validation, which provides 91.6%
probability to confirm a variant. Of the 39 successful reactions, 18
are determined as sequencing errors, 8 are confirmed as true
homozygous variants in the individual genome, and 13 are
Table 1. Exome data collected from neutrophils and CD4+ T
cells.
items Neutrophils CD4+ T cells
Total sequenced bases 14,686,433,331 13,784,953,286
Exome coverage 237 222
Targeted exon by exome kit 201,046 (100%) 201,046 (100%)
Captured exon by exome sequencing 197,988 (98.5%) 197,565 (98.3%)
Exons common in neutrophils and T cells 196,749 (97.9%) 196,749 (97.9%)
Missed exons by exome sequencing 3,058 3,481
Missed in both cell types 2,242 2,242
Missed in neutrophils 816 –
Missed in CD4+ T cells – 1,239
doi:10.1371/journal.pone.0078685.t001
Table 2. SNVs detected in neutrophils and CD4+ T cells.
Cell type SNV SNV distribution
Common in both cell types Only in single cell type
Neutrophils 150,719 (100%) 141,034 (94%) 9,685 (6%)
CD4+ T cells 150,203 (100%) 141,034 (94%) 9,169 (6%)
doi:10.1371/journal.pone.0078685.t002
Figure 1. PCR detection of the missed exons. One hundred of missed exons were selected for the validation and 90 generated positive results.
Except #73, all 89 reactions detected the missed exons with the same sizes between T cells and neutrophils. T: CD4+ T cells; N: neutrophils.
doi:10.1371/journal.pone.0078685.g001
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validated as heterozygous variants but misinterpreted by mapping
program (Table 3). Therefore, the variants mapped differently
between T cells and neutrophils are mostly caused by sequencing
errors or miscalling in the mapping process. TCR loci in T cells
can be highly polymorphistic due to VDJ recombination. We
compared the sequences from neutrophils and T cells mapped to
the TCR-related loci (TCR-alpha and TCR-delta, chr14:22,205,021-
23,021,097; TCR-beta, chr7:142,000,946-142,945,186; TCR-gamma,
chr7:38,288,844-38,403,119; and PTCRA, chr6:42,883,727-42,893,575),
but we did not find any coding differences for these loci between the
two cell types. We also compared the exome data between neutro-
phils and CD19+ B cells of the same individual, and also not
observed any diffferences (data not shown).
Myeloid cell lineage undergoes rapid differentiation and
dramatic nuclear morphological change. While it remains
unknown if any sequence changes in the non-coding regions
could occur during myeloid differentiation and certain very rare
mutations can exist in the coding regions [14], our study shows
that the coding genes in polymorphonuclear neutrohophils remain
essentially the same as the intact genome. Our study suggests that
the chromosomes in myeloid cells remain linear chromatin
structure regardless the morphological changes during myeloid
differentiation. Our study concludes that genomic DNA from
myeloid lineage cells can be safely used in genetic studies.
Methods
Ethics Statement: The cells used for the study were obtained
from AllCells LLC (http://www.allcells.com/, Emeryville, Cali-
fornia), which has its full IRB system (Biomed IRB) for providing
human blood cells from donors for research. The donor signed the
written consent form, which is archived with their medical records.
According to US Federal Regulations, 45 CFR Part 46.101(b)(4)–
Protection of Human Subjects, using this type of human cells for
research is exempted from the requirement for IRB review.
Peripheral leukapheresis blood was collected from a healthy
Caucasian male donor, with cell count of red blood cells of
4.766103/mm3, and leukocyte differentiation of lymphocytes
1.76103/mm3 (23.0%), monocytes 0.36103/mm3 (4.7%), and
granulocytes of 5.86103/mm3 (72.3%). The collected blood
sample was used immediately for cell purification: red blood cells
were depleted by sedimentation using the HetaSep solution (Stem
Cell Technologies); neutrophils were isolated by using the EasySep
human Neutrophil Enrichment Kit (Stem Cell Technologies);
mononuclear cells were isolated by using Ficoll solution (GE
Healthcare) and CD4+ helper T cells were isolated from the
mononuclear cells using the StemSep human Naı¨ve CD4+ T Cell
Enrichment Kit (Stem Cell Technologies). The purity of the
isolated cells was determined by FACS analysis with 90% for
neutrophils and 97% for CD4+ T cells. DNA was extracted from
the purified cells by using the FlexiGene DNA kit (QiaGen).
Exome DNA was capyured from DNA sample of neutrophils
and CD4+ T cells using Illumina TruSeq exome enrichment kit
following manufacturer’s protocols (http://www.illumina.com/
products/truseq_exome_enrichment_kit.ilmn). Paired-end exome
sequencing (26100) was performed at 200x exome coverage per
sample using an Illumina Hiseq 2000 sequencer. Sequences from
each cell type were compared to the 201,046 exons covered by the
Illumina TruSeq exome enrichment kit (Illumina TruSeq Exome
Targeted Region database 1.3.0). Exome sequences were mapped
to the human genome reference sequences (hg19) using BWA-SW
[15] and SAMtools [16] with default parameters. Variations were
called using VarScan 2 [17] on the conditions of minimum
coverage .10, minimum variation frequency .0.2, minimum
average quality score .30, and p-value ,0.05. The called
variations were searched in dbSNP135 for SNP identification.
Table 3. Sanger sequencing validation for single-base
differences between neutrophils and T cells.*
Position hg19 Mapped variants Validation
T N T N
Sequencing error
chr1:148252811 T A wt T T
chr2:174939985 G T wt G G
chr9:68455295 C A wt C C
chr12:123893145 C T wt C C
chr16:31002833 G A wt G G
chr16:72763868 C A wt C C
chr17:58286681 G C wt G G
chr19:58002709 C T wt C C
chr20:26258754 T G wt T T
chrY:10028388 A G wt A A
chr1:143398955 T wt C T T
chr5:49440947 C wt G C C
chr16:19502080 C wt T C C
chr17:7733570 T wt G T T
chr21:9650474 G wt T G G
chrX:123199635 G wt T G G
chrY:28780697 G wt A G G
chrY:28780699 C wt G C C
Homozygous SNVs
chr4:170990053 C T wt T T
chr9:3270683 C T wt T T
chr14:105270485 G T/+T wt +T +T
chr17:48313505 G T wt T T
chr10:33134724 T wt C C C
chr10:30305222 T wt G G G
chr11:120338142 C wt T T T
chr14:24887303 A wt C 2A 2A
Heterozygous SNVs
chr1:2980578 C T wt C/T C/T
chr5:137290214 T C wt T/C T/C
chr8:139160613 A G wt A/G A/G
chr17:36333536 A C wt A/C A/C
chr22:25006880 G A wt G/A G/A
chr1:149724356 G wt A G/A G/A
chr3:111577836 A wt T A/T A/T
chr3:189713346 T wt G T/G T/G
chr3:195295510 A wt G A/G A/G
chr15:20867219 A wt G A/G A/G
chr19:55221804 G wt +AC G/C G/C
chr19:55281149 C wt T C/T C/T
chr21:10897305 C wt T C/T C/T
*wt: wild type; +: insertion, 2: deletion, /: heterozygote.
doi:10.1371/journal.pone.0078685.t003
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PCR and Sanger sequencing were used to validate the missed
exons and single-based variants identified by exome mapping. We
performed a statistical analysis to determine the proper number of
candidates for the validations. Assuming the missed exons and
variants occur at random with probability , the number of the
missed exons and variants in sequenced candidates will follow a
binomial distribution . Then the probability of at least missed
exons and variants is
where represents binamial random variable, represents minimal
number of missed exons or variants, represents binomial
distribution, represents total sample size. The rate of missed exons
is 0.021. Testing 100 candidates will provide 0.880 chance to
detect each missed exon; the rate of single base variants is 0.06.
Testing 40 candidates will provide 0.916 chance to detect a variant
[18].
PCR primers were designed by Primer3 (http://frodo.wi.mit.
edu/primer3/). PCR was performed with DNA (20 ng/reaction),
sense and antisense primers (10 pmol), and GoTaqH DNA
polymerase (1.25 unit, Promega) at the conditions of denaturing
at 95uC 7 minutes, 37 cycles of 95uC 30 seconds, 57uC 30 seconds,
72uC 45 seconds, final extension at 72uC 7 minutes. PCR products
were checked on 2% agarose gels. For these to be sequenced, each
was purified using an Illustra GFX 96PCR Purification kit (GE
Healthcare), and sequenced using BigDye Terminator v3.1 in an
ABI3730 DNA sequencer (Applied BioSystems).
The exome data from neutrophils and CD4+ T cells have been
deposited in NCBI, pending for assigned accession. The exome
data from neutrophils and CD4+ T cells have been deposited in
NCBI, with accession number SRR933550 for Neutrophils and
SRR933549 for CD4+ T cells.
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